NO152510C - Analogifremgangsmaate til fremstilling av en terapeutisk virksomm 7beta-(d-2-amino-2-(3-c1-c4-alkyl-sulfonylaminofenyl)-acetylamino)-3-r-3-cefem-4-karboksylsyre - Google Patents

Analogifremgangsmaate til fremstilling av en terapeutisk virksomm 7beta-(d-2-amino-2-(3-c1-c4-alkyl-sulfonylaminofenyl)-acetylamino)-3-r-3-cefem-4-karboksylsyre

Info

Publication number
NO152510C
NO152510C NO762864A NO762864A NO152510C NO 152510 C NO152510 C NO 152510C NO 762864 A NO762864 A NO 762864A NO 762864 A NO762864 A NO 762864A NO 152510 C NO152510 C NO 152510C
Authority
NO
Norway
Prior art keywords
sulphonylaminophenyl
7beta
cefem
carbo
acetylamino
Prior art date
Application number
NO762864A
Other languages
English (en)
Other versions
NO762864L (no
NO152510B (no
Inventor
Rene Wiederkehr
Hans Bickel
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO762864L publication Critical patent/NO762864L/no
Publication of NO152510B publication Critical patent/NO152510B/no
Publication of NO152510C publication Critical patent/NO152510C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
NO762864A 1975-08-20 1976-08-19 Analogifremgangsmaate til fremstilling av en terapeutisk virksomm 7beta-(d-2-amino-2-(3-c1-c4-alkyl-sulfonylaminofenyl)-acetylamino)-3-r-3-cefem-4-karboksylsyre NO152510C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1082275A CH622802A5 (no) 1975-08-20 1975-08-20

Publications (3)

Publication Number Publication Date
NO762864L NO762864L (no) 1977-02-22
NO152510B NO152510B (no) 1985-07-01
NO152510C true NO152510C (no) 1985-10-09

Family

ID=4367199

Family Applications (1)

Application Number Title Priority Date Filing Date
NO762864A NO152510C (no) 1975-08-20 1976-08-19 Analogifremgangsmaate til fremstilling av en terapeutisk virksomm 7beta-(d-2-amino-2-(3-c1-c4-alkyl-sulfonylaminofenyl)-acetylamino)-3-r-3-cefem-4-karboksylsyre

Country Status (35)

Country Link
US (1) US4069324A (no)
JP (1) JPS5225794A (no)
AR (2) AR215247A1 (no)
AT (1) AT348119B (no)
AU (1) AU501362B2 (no)
BE (1) BE845320A (no)
BG (5) BG27560A4 (no)
CA (1) CA1090331A (no)
CH (5) CH622802A5 (no)
CS (6) CS193584B2 (no)
CY (1) CY1165A (no)
DD (1) DD127142A5 (no)
DE (1) DE2636962A1 (no)
DK (1) DK374576A (no)
ES (1) ES450775A1 (no)
FI (1) FI66619C (no)
FR (1) FR2321293A1 (no)
GB (1) GB1551931A (no)
GR (1) GR61656B (no)
HK (1) HK12083A (no)
HU (1) HU179140B (no)
IE (1) IE43717B1 (no)
IL (1) IL50298A (no)
MY (1) MY8400030A (no)
NL (1) NL7609240A (no)
NO (1) NO152510C (no)
NZ (1) NZ181804A (no)
OA (1) OA05419A (no)
PH (1) PH12931A (no)
PL (4) PL110983B1 (no)
PT (1) PT65494B (no)
RO (7) RO74667A (no)
SE (1) SE437990B (no)
SU (7) SU847923A3 (no)
ZA (1) ZA764980B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5498489U (no) * 1977-12-22 1979-07-11
JPS5418379U (no) * 1978-08-14 1979-02-06
JPS57140307U (no) * 1981-02-27 1982-09-02
SE438477B (sv) * 1983-02-28 1985-04-22 Gote Hakansson Anordning vid vagnar
US4927943A (en) * 1984-09-04 1990-05-22 Bristol-Myers Company Substituted 7-oxomitosanes
KR960704897A (ko) * 1994-07-22 1996-10-09 에밀리오 마우리 글루타릴 7-아미노세팔로스포란산 유도체 및 이의 제조 방법 (Glutaryl 7-ACA derivatives and processes for obtaining them)
CN103387584B (zh) * 2013-07-17 2015-02-25 盐城开元医药化工有限公司 一种7-氨基-3-氯-3-头孢环-4-羧酸的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206201A1 (es) * 1972-06-29 1976-07-07 Ciba Geigy Ag Procedimiento para la obtencion de compuestos de acido 7beta-amino-3-cefem-3-01-4-carboxilico0-substituidos
US3917587A (en) * 1972-11-28 1975-11-04 Lilly Co Eli Cephalosporin ethers
YU36970B (en) * 1973-02-23 1984-08-31 Lilly Co Eli Process for obtaining 7-(amino)-acylamido-3-halocephalosporins
US3925372A (en) * 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
AR208068A1 (es) * 1973-02-23 1976-11-30 Lilly Co Eli Un procedimiento para preparar derivados de acidos 7-acilamido-3-halo-cefem-4-carboxilico los esteres y las sales farmaceuticamente aceptables de los mismos
AR205537A1 (es) * 1973-05-10 1976-05-14 Fujisawa Pharmaceutical Co Procedimiento para la preparacion de derivados de acido 7-substituido fenilglicinamido - 3 - substituido - 3 - cefem - 4 - carboxilicos
US3994887A (en) * 1973-05-17 1976-11-30 Recherche Et Industrie Therapeutiques (R.I.T.) 7-(3-Substituted ureido) cephalosporins
DE2432190A1 (de) * 1973-07-06 1975-01-23 Fujisawa Pharmaceutical Co Neue chemische verbindungen, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zubereitungen
US3998819A (en) * 1973-12-26 1976-12-21 Smithkline Corporation Trifluoroethyl-mercapto, -sulfinyl or -sulfonyl acetamidocephalosporins
US3985746A (en) * 1975-03-25 1976-10-12 E. R. Squibb & Sons, Inc. 7-(α-Cyanomethylthio)acetamido-3-cephem carboxylates
US4008230A (en) * 1975-10-29 1977-02-15 Eli Lilly And Company Process for preparing 3-hydroxy cephalosporins

Also Published As

Publication number Publication date
NZ181804A (en) 1978-04-28
PH12931A (en) 1979-10-17
CH622802A5 (no) 1981-04-30
MY8400030A (en) 1984-12-31
IE43717B1 (en) 1981-05-06
GB1551931A (en) 1979-09-05
FI762381A (no) 1977-02-21
SU715029A3 (ru) 1980-02-05
CS193585B2 (en) 1979-10-31
PT65494A (en) 1976-09-01
RO75412A (ro) 1980-12-30
ZA764980B (en) 1977-07-27
RO75071A (ro) 1980-10-30
FI66619B (fi) 1984-07-31
CS193560B2 (en) 1979-10-31
CS193584B2 (en) 1979-10-31
HU179140B (en) 1982-08-28
NO762864L (no) 1977-02-22
SU670224A3 (ru) 1979-06-25
RO74687A (ro) 1980-10-30
PL191915A1 (pl) 1978-10-23
RO69463A (ro) 1980-08-15
CH622803A5 (no) 1981-04-30
SU719505A3 (ru) 1980-02-29
IL50298A0 (en) 1976-10-31
SU847923A3 (ru) 1981-07-15
DK374576A (da) 1977-02-21
US4069324A (en) 1978-01-17
DD127142A5 (no) 1977-09-07
SU680650A3 (ru) 1979-08-15
GR61656B (en) 1978-12-05
AU1698576A (en) 1978-02-23
BG27559A4 (en) 1979-11-12
CH622805A5 (no) 1981-04-30
ATA615476A (de) 1978-06-15
NO152510B (no) 1985-07-01
DE2636962A1 (de) 1977-03-03
IL50298A (en) 1979-05-31
AR215247A1 (es) 1979-09-28
PL108059B1 (pl) 1980-03-31
CY1165A (en) 1983-06-10
AU501362B2 (en) 1979-06-21
CH622806A5 (no) 1981-04-30
JPS5225794A (en) 1977-02-25
BG27561A4 (en) 1979-11-12
CA1090331A (en) 1980-11-25
OA05419A (fr) 1981-03-31
SE437990B (sv) 1985-03-25
CS193588B2 (en) 1979-10-31
CS193586B2 (en) 1979-10-31
CH622804A5 (no) 1981-04-30
DE2636962C2 (no) 1987-07-02
CS193589B2 (en) 1979-10-31
JPS6152158B2 (no) 1986-11-12
RO74667A (ro) 1980-10-30
RO75411A (ro) 1980-11-30
RO74668A (ro) 1980-10-30
SU803862A3 (ru) 1981-02-07
PL110983B1 (en) 1980-08-30
AR214791A1 (es) 1979-07-31
PT65494B (en) 1978-02-13
ES450775A1 (es) 1977-10-01
SU719506A3 (ru) 1980-02-29
IE43717L (en) 1977-02-20
PL110876B1 (en) 1980-08-30
AT348119B (de) 1979-01-25
PL108107B1 (pl) 1980-03-31
SE7609222L (sv) 1977-02-21
FR2321293A1 (fr) 1977-03-18
FR2321293B1 (no) 1979-01-12
FI66619C (fi) 1984-11-12
BG27558A3 (en) 1979-11-12
NL7609240A (nl) 1977-02-22
BG27560A4 (en) 1979-11-12
BG27561A3 (bg) 1979-11-12
BE845320A (fr) 1977-02-21
HK12083A (en) 1983-04-07

Similar Documents

Publication Publication Date Title
NO151746C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt penicillansyre-1,1-dioksyd
NO148703C (no) Fremgangsmaate til fremstilling av polyurea-mikrokapsler
NO146845C (no) Fremgangsmaate til fremstilling av en palladiumkatalysator
SE433804B (sv) Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt
SE431089B (sv) Forfarande for framstellning av beta-metyltio-propionaldehyd
SE7804397L (sv) Forfarande for framstellning av en tetradekapeptid
SE7611241L (sv) Forfarande for framstellning av medicintablett
NO142174C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 1,1-diaryl-1-oksadiazol-alkylaminer
SE429336B (sv) Forfarande for framstellning av salicylanilidderivat med parasiticidaktivitet
NO784281L (no) Fremgangsmaate til fremstilling av nye 2alfa-cyano-3-okso-steroider
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
DK158836C (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive anthraquinonderivater
NO144926C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-benzazolylalkyl-4-substituerte piperidiner
NO148375C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3-klor-7-alfa-amino-acylcefalosporinforbindelser
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
NO152510C (no) Analogifremgangsmaate til fremstilling av en terapeutisk virksomm 7beta-(d-2-amino-2-(3-c1-c4-alkyl-sulfonylaminofenyl)-acetylamino)-3-r-3-cefem-4-karboksylsyre
FI56113C (fi) Anordning foer lyftning av en saengbunden patient
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
NO147672C (no) Analogifremgangsmaate for fremstilling av n-aryl-n-(1-l1-4-piperidinyl)-arylacetamider
SE7802603L (sv) Forfarande for framstellning av terapeutiska medel
SE442375B (sv) Forfarande for framstellning av en komposition for behandling av klimakteriska besver
SE7705851L (sv) Forfarande for framstellning av en farmaceutisk komposition
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
NO151861C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-substituert-10,11-dihydro-5h-dibenzo-(a,d)-cyclohepten-5,10-iminer